Brief: Chromadex Corp- Debuts Clinical Strength Tru Niagen Pro 1,000Mg
01/11/2023 12:38
Nov 1 (Reuters) - Chromadex Corp CDXC.O :
* CHROMADEX CORP- DEBUTS CLINICAL STRENGTH TRU NIAGEN PRO
1,000MG
FEATURING NIAGEN (PATENTED NICOTINAMIDE RIBOSIDE), TO CONSUMERS
NATIONWIDE
Source text for Eikon: ID:nBw7Th4qMa
Further company coverage: CDXC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Niagen Bioscience
See all newsAs weight-loss drug users turn to dietary supplements, doctors, regulators raise flags
Niagen Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Niagen Bioscience Q2 net sales fall, missing estimates
Niagen Bioscience Inc expected to post earnings of 2 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Salesforce